Literature DB >> 11037714

Changes in the extracellular matrix of the vein wall--the cause of primary varicosis?

D Kirsch1, H P Dienes, R Küchle, H Duschner, W Wahl, T Böttger, T Junginger.   

Abstract

BACKGROUND: Conflicting theories on the development of primary varicosis have led to the molecular biological investigation of the vein wall or, more accurately, of the extracellular matrix. It was the aim of this study to quantify matrix expression and to compare pathological changes in the vein wall with valve-orientated staging of varicosis, in order to determine indicators of the primary cause of varicosis.
MATERIALS AND METHODS: Three hundred seventy-two tissue specimens of greater saphenous veins were obtained from 17 patients with varicosities and categorised according to Hach stage and procurement site. The specimens were compared with 36 specimens collected from six patients without varicosities, incubated with fluorescence-stained antibodies for collagen 4, laminin, fibronectin and tenascin prior to being assessed with confocal laser scan microscopy. In addition, 22 vein specimens (16 varicose, 6 normal veins) serving as negative controls were investigated.
RESULTS: Image analysis and statistical evaluation showed that compared with normal veins, varicose veins are associated with a significant increase in matrix protein expression for collagen 4, laminin and tenascin. A trend towards an increase in matrix expression was further observed for fibronectin. There was, however, no difference between varicose veins and clinically healthy vein segments inferior to a varicose segment.
CONCLUSION: If the findings of the present investigation can be confirmed by other studies, alterations in the vein wall may be regarded as the primary cause of varicosis and valvular insufficiency as the result of these changes.

Entities:  

Mesh:

Substances:

Year:  2000        PMID: 11037714     DOI: 10.1024/0301-1526.29.3.173

Source DB:  PubMed          Journal:  Vasa        ISSN: 0301-1526            Impact factor:   1.961


  10 in total

1.  Does extracellular matrix of the varicose vein wall change according to clinical stage?

Authors:  Mehmet Ali Demirkıran; Cüneyt Köksoy; Aylin Okçu Heper; Uğur Bengisun
Journal:  Ulus Cerrahi Derg       Date:  2014-12-01

Review 2.  Matrix metalloproteinases as potential targets in the venous dilation associated with varicose veins.

Authors:  Arda Kucukguven; Raouf A Khalil
Journal:  Curr Drug Targets       Date:  2013-03       Impact factor: 3.465

3.  Endothelium-dependent nitric oxide and hyperpolarization-mediated venous relaxation pathways in rat inferior vena cava.

Authors:  Joseph D Raffetto; Peng Yu; Ossama M Reslan; Yin Xia; Raouf A Khalil
Journal:  J Vasc Surg       Date:  2011-12-30       Impact factor: 4.268

4.  Impact of elevated serum estradiol/free testosterone ratio on male varicose veins in a prospective study.

Authors:  Sedat Özcan; Dolunay Odabasi; Tolga Kurt; Ali Kemal Gür; Aysegul Kunt; Yavuz Balaharoglu; Alper Sami Kunt
Journal:  Wien Klin Wochenschr       Date:  2014-11-20       Impact factor: 1.704

Review 5.  Matrix Metalloproteinases in Remodeling of Lower Extremity Veins and Chronic Venous Disease.

Authors:  Yunfei Chen; Wei Peng; Joseph D Raffetto; Raouf A Khalil
Journal:  Prog Mol Biol Transl Sci       Date:  2017-03-21       Impact factor: 3.622

6.  Prolonged increases in vein wall tension increase matrix metalloproteinases and decrease constriction in rat vena cava: Potential implications in varicose veins.

Authors:  Joseph D Raffetto; Xiaoying Qiao; Vera V Koledova; Raouf A Khalil
Journal:  J Vasc Surg       Date:  2008-05-23       Impact factor: 4.268

7.  Mechanisms of Lower Extremity Vein Dysfunction in Chronic Venous Disease and Implications in Management of Varicose Veins.

Authors:  Joseph D Raffetto; Raouf A Khalil
Journal:  Vessel Plus       Date:  2021-05-29

8.  Tissue remodeling investigation in varicose veins.

Authors:  Sayyed Mohammad Hossein Ghaderian; Zohreh Khodaii
Journal:  Int J Mol Cell Med       Date:  2012

Review 9.  Vascular proteomics in metabolic and cardiovascular diseases.

Authors:  M Lynch; J Barallobre-Barreiro; M Jahangiri; M Mayr
Journal:  J Intern Med       Date:  2016-03-04       Impact factor: 8.989

Review 10.  Latest Innovations in the Treatment of Venous Disease.

Authors:  Robert R Attaran
Journal:  J Clin Med       Date:  2018-04-11       Impact factor: 4.241

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.